Interleukin-31: A novel diagnostic marker of allergic diseases

73Citations
Citations of this article
79Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Interleukin-31 (IL-31) is a newly discovered cytokine associated with chronic skin inflammation and pruritus. Patients with atopic dermatitis, chronic spontaneous urticaria, allergic contact dermatitis, prurigo nodularis, primary cutaneous lymphoma and mastocytosis exhibit increased serum levels of IL-31 protein and elevated IL-31 mRNA in the skin. Interestingly, in some of these diseases, IL-31 serum levels correlate with disease activity. In the present review, we particularly focus on studies investigating IL-31 as a novel diagnostic biomarker indicating the severity of allergic diseases. We highlight a recent study on IL-31 in mastocytosis, which reports on elevated serum levels of IL-31 in adults correlating with the severity of disease categories, tryptase levels and percentage of bone marrow infiltration. We conclude that growing knowledge about IL-31, its receptors and signaling pathways serves to better understand the pathogenesis of allergic diseases and may lead to the development of novel treatment approaches. © 2014 Springer Science+Business Media.

Cite

CITATION STYLE

APA

Rabenhorst, A., & Hartmann, K. (2014). Interleukin-31: A novel diagnostic marker of allergic diseases. Current Allergy and Asthma Reports, 14(4). https://doi.org/10.1007/s11882-014-0423-y

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free